| NANOBIOTIX INH. EO-,03 |
| Frankreich |
| Gesundheit |
| FR0011341205 / A1J7EB |
| 5NR (Frankfurt) |
| FRA:5NR, ETR:5NR, 5NR:GR |
| - |
| https://www.nanobiotix.co.. |
|
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United States, it pioneers nanotechnology that enhances ..
>Volltext.. |
| 2128.3 Mio. EUR |
| 2171.03 Mio. EUR |
| 29.95 Mio. EUR |
| -12.34 Mio. EUR |
| -24.21 Mio. EUR |
| -0.5 EUR |
| 96.3 Mio. EUR |
| 53.29 Mio. EUR |
| - |
| 0.92 |
| -1.38% |
| 39.64% |
| - |
| - |
| - |
| - |
| NANOBIOTIX |
| 17.05.26 |
|
||||
|
||||
|